Antihypertenseur, Activité Vasorelaxant De Rouppelinia Boivinni (Apocynaceae) Et Etude De Relation Structure-Activité Des Alcaloïdes Indoliques Isolées

Rainimanantsoa Jonesusbel, Tiandreniny Jipaty, Fiatoa Barthelemy, Herindrainy Audiat Miller, Andrianjara Charles, Fatiany Pierre Ruphin


In the southern and south-western regions of Madagascar, traditional medicine plays an important role in society. Ethnobotanical surveys carried out in these regions have revealed that the plant known under the vernacular name "Feka (nom Mahafaly, Masikoro); Fekambato (Nom Antandroy); Fekakely (Nom Sakalava)" is used by the local population to treat hypertension. The results of biological tests (in-vivo and in-vitro) carried out on the alkaloid extract show improved vasorelaxant activity. These results justify their therapeutic virtues. Bioguided fractionation of the alkaloid extract from the aerial part of this plant resulted in the isolation of two pure products, PX-1 and PX-2. The chemical structures of these two pure products were isolated using spectral analysis methods. The ultraviolet spectrum of the PX-1 molecule recorded by LHPC-UV-DAD shows an absorption maximum at 240nm and 317nm, indicating the presence of an acylindole chromophore in PX-1. The peak at Tr= 2.9min corresponds to the molecular ion peak at m/z =355.20141 [M+H]+, corresponding to the empirical formula C21H26N2O3. Product PX-2 has a molecular weight of m/z = 352.17896 [M+H]+, corresponding to the molecular formula C21H24N2O3, and its UV spectrum recorded by HPLC-UV-DAD shows absorption maxima at 240nm and 317nm consistent with the 2-acyl indole chromophore. Analysis by nuclear magnetic resonance spectroscopy (1D and 2D NMR) confirms that the basic structures of PX-1 and PX-2 are attributed to indole alkaloids. Analysis of the pharmacological mechanism of this plant's vasorelaxant activity shows that the relaxant activity may result from blockade of calcium influx through vascular smooth muscle cells, as the contraction produced by CaCl2 on the aorta in a calcium-free depolarizing medium was inhibited by the alkaloid extract in a concentration-dependent manner with EC50= 0.061±0.0056mg/ml at n=7. Preliminary acute and chronic toxicity studies carried out on the alkaloid extract of this plant showed no significant toxic signs. In perspective, the study of the plant used in medicine to treat TAH enables the isolation of two indole-type alkaloids and the discovery of their mechanisms of pharmacological activity. It's time for researchers to turn to traditional medicine as an inexhaustible source of scientific discovery.


Antihypertensive, vasorelaxant, Rouppelinia boivinni, Traditional medicine, Indole alkaloid

Full Text:



Chobanian AV, 2001. Control of hypertension, an important national priority. New England Journal of Medecine, 345(7) : 534-538.

Chamontin Bernard, 1997. HAT de l’adulte : Epidémiologie, étiologie, physiopathologie, diagnostic, évolution, prognostic, traitement de l’hypertension essentielle. Revue du praticien Paris France ; 122 – 132p.

Bouvenot G, Devulder B, Guillevin L, Queneau P, Schaeffer A, 1994. Abrégés de Pathologie médicale. Pneumologie, Néphrologie, Cancérologie, Nutrition ; Edition Masson, Paris ; 506 p.

Arama Remi Erè, 1988. Contribution au traitement traditionnel de l’HTA. Thèse de Pharmacie, Bamako, 88p.

Mancia G, 2007. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25 : 1105 – 1187.

Rabarijaona LMPH, Rakotomalala DP, Rakotonirina, ELCJ, Rakotonirina S, 2009.

Prévalence et sévérité de l’HTA de l’adulte en milieux urbaine à Antananarivo. Revue d’urgence; 1: 24-27.

Keqrney PM, Whelton M, Reynolds K, 2005. Global burden of hypertension: analys of worldwide data. Lancet ; 365, No 9455 :217-23.

OMS, 1983. Prévention primaire de l’hypertension essentielle. OMS Rapport d’un groupe scientifique ; Bulletin de l’OMS : Série des rapports techniques N° 683 Genève ; 45p.

Mounier Vehier.C, 2002. Evaluation stratification du risque cardiovasculaire selon les recommandations de l’ANAES 2000, dans une propulsion hypertensive. Archives des maladies et des vaisseaux, 95 (7-8) : 667 – 672.

Nghonguia Madeliene, 2001. Exploration de HTA maligne chez les insuffisantes rénales chroniques dans le service de néphrologie de l’hôpital National de Point « G ». Thèse de Médecine: Bamako, 66p.

Redwood H, 2007. Hypertension, society and public policy. Eur Heart. J. Suppl. 9 :13-18.

Delbarre B, Delbarre G, 1993. Abrégé de l’HTA : Physiopathologie et pharmacologie. Edition Masson Paris, 102p.

Dahlöf B, 2000. Cardiovascular Intervention for Endpoint Reduction in Hypertension study (LIFE). Arandomised trial against atenolol; Lancet 359: 995-1003.

Hamburger J, Grünfeld JP, Auvert J, Lhermitte F, Pascal VR, 1966. Collection médico-chirurgicale : Néphrologie et urologie 3ème édition vol. 7, Flammarion Médecine Sciences ; 20 Rue de Vaugirard Paris ; 669p

Fourcade L, 2007. Arterial hypertension in Sub-Saharian Africa; uptade and perspective Medecine tropicale: Revue du corps de santé colonial, 67(6): 559-567.

Meyer Philippe, 1978. HTA : mécanismes, cliniques et traitement, Edition Flammarion, Paris France ; 174p.

Leon Perlemuter, Gabriel Perlemuter, 2006. Guide thérapeutique 5ème édition Publié par Elsevier Masson : 933.

Fatiany Pierre Ruphin, Robijaona Baholy, Randrianarivo Emmanuel, Raharisololalao Amelie, Marie Therese-Martin, Ngbolua Koto-te Nyiwa, 2014. Isolation and structural elucidation of cytotoxic compound from the root bark of Diospyros quercinia (Baill.) endemic to Madagascar. Asian Pacific Journal of tropical Biomedicine, 4(3): 780-784.

Fatiany Pierre Ruphin, Fiatoa Barthelemy, Raoelson Guy, Randrianirina Aubin Oscar, Randriantsoa Adolph, Andrianjara Charles, Minjée Zhao, Eric Marchioni, Robijaona Baholy, Solofonirina Marchelin, Ngbolua Koto-te Nyiwa, 2016. Effects of Cymbopogon pruinosus (Poaceae) form Madagascar on isolated rat thoracic aorta and structural elucidation of its two bioactive compounds. Journal of Pharmacognosy and Phytochemistry; 5(1): 46-55. Available online at

Fatiany Pierre Ruphin, 2015. Recherche de molécules Bioactives sur les extraits et les mélanges complexes volatiles issus de quelques espèces de plantes médicinales et aromatiques du Sud-ouest de Madagascar. Mémoire d’habilitation à diriger de Recherches, Faculté des Sciences, Université de Toliara-Madagascar, p 63.

Chhabra SC, Mahunnah RLA, Mshiu EN, 1998. Plant used in traditional Medecine in Eastern Tanzania. J. of Ethnopharmacology; 25(3): 339 – 359.

Dandouau D, Schripsema J, Verpoorte R, 1994. Charmes et Remèdes. Bulletin de l’Académie Malagasy-XI.

Pousset JL, 2004. Plantes Médicinales d’Afriques. Comment les utiliser. Secum/Edisud, 287p.

Rabesandratana R, 1986. Résultats des enquêtes et localisation des plantes médicinales de la région de Toliara. Annales des Universités de Madagascar, série de la Nature et Mathématique, 13 ; 131.

Boullard Bernard, 2001. Dictionnaires des plantes médicinales du monde. Réalités et croyances ; Edition ESTEM, Paris, 636 p.

Clapham DE, 1995. Calcium signaling. Cell I; 80:259 – 268.

Dietz JD, 2008. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. Hypertension; 51:742 – 748.

Corder R, Doutwaile JA, Khan NQ, Lees DM, Santos VD, 2006. Endothelium-1 synthesis reduced by red wine; Nature, 414 (6866): 863 – 864.

Flesh M, Scwaez A, Bolum M, 1998. Effect of red and white wine on endothelium dependent vasorelaxant of rat aorta and human coronary arteries. Am J Physiol Heart Cire Physiol; 275:1183.

Fitzpatrick DF, Hirschfield SI, Coffey RG, 1993. Endothelium dependent vasorelaxant activity of wine and other grape product; Am J Physiol; 265:11774.

Grassi-kassisse DM, Wolf-Nunes V, Miotto AM, Farias SE, Brito ARMS, Nune DS, Spadari-Bratfisch RC, 2003. Sensivity to β-adrenoceptor agonist of adipocytes from rats treated whit an aqueous extract of croton cajucara benth. Journal of Pharmacy and Pharmacology; 55: 253 – 257.

Lincoln TM, Cornewll TL, 1993. Intracellular cyclic GMP receptor protein. Faseb J, 7: 328 – 338.

Pandey KN 2011. Guanylylcyclase/peptide receptor-A: role in the pathophysiology of cardiovascular regulation. Can. J. Physiol. Pharmacol; 89: 557-573

Reboldi, 2008. Comparison between Angiotensin-converting enzyme inhibitors and angiotensin receptors blockers. Journal of hypertension; 26(1):1282-1286.

Maeda H, Akaike T, Yoshida M, Sunga M, 1994. Multiple function of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. Journal of leucocyte Biology; 56: 588 – 592.

Moncada S, Higgs EA, 1993. The l-arginine nitric oxide pathway. N Engl J Med. 329: 2002

Mei L, Deng Y, Li F, Dale G, Chongyu L, 2012. Study on the alkaloids constituents from voacanga Africana. Zhongyaocai ; 35(2) : 226-229.

Mansoor TA, Ramalho RM, Mulhovo S, Rodrigues CMP, Ferreira MJU, 2009. Induction of apoptosis in HuH-7 cancer cells by monoterpène and carboline indole alkaloids isolated from the leaves of Tabernaemontaneae elegans. Bio. Org. Med. Chem. Letters; 19: 4255 – 4258.

Nugroho AE, Hirasawa Y, Kawaraha N, Goda Y, Awang K, Hadi AHA, Morita H, 2009. Bisnicalayerine A, a Vobasine bisindole Alkaloid from Hunteria zelanica. Journal Natural Product 72: 1502 – 1506.

Henriques AT, Melo A, Moreno PRH, Ene L, Henriques JAP, Schapoval ESE, 1996. Ervatamia coronaria: chemical constituents and some pharmacological activities. Journal Ethnopharmacology; 50, 19 – 25.

Lane D A, Shah S, Beevers DG, 2007. Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J. Hypertension, 25: 891 – 894.

Liang S, Chen H, Jin Y, Jin L, Jia L, Jingling D, 2007. Chemical constituents from twigs and leaves of Ervatamia hainanensis Zhongguo Zhongyao Zazhi; 32(13): 1296 – 1299.

Schripsema J, Dagnino D, Santos RD, Verpoorte R, 1994. Breakdown of indole Alkaloids in suspension cultures of Tabernaemontanana divaricate and Cantharanthus roseus. Plant Cell, Tisue Organ Cult; 38:299-305.

Schneider JA, Sigg EB, 1957. Neuropharmacological studies on Ibogamine, an indole alkaloid with central stimulant properties. Ann. N Y Acad Sci; 66: 756-6.

Pace CJ, Glick SD, Maisonneuve IM, 2004. Novel iboga alkaloids congeners block nicotinic receptors and reduce drug self-administration. European Journal Pharmacology; 492: 159-67.

Mehrotra PK, Kamboj VP, 1978. Hormonal profile of coronaridine hydrochloride –an antifertility agent of plant origin. Planta Med; 33: 345-9.

Chen G, Bohner B, 1958. A study of central nervous stimulant. J Pharmacol Exp Ther; 123: 215-5.

Goutared R, Gollnhofer O, Sillans R, 1993. Pharmacodynamic and therapeutic applications of iboga and ibogaine in psychotherapy and for controlling narcotic dependence. Psychedelic Monograph Essays; 6: 70 – 111.

Dagnino D, Schripsema J, Verpoorte R, 1993. Comparison of terpenoid indole alkaloid production and degradation in two cell lines of Tabernaemontanana divaricate. Plant. Cell. Rep; 13: 95-8.

Van-Beek TA, Verpoorte R, Kinh PQ, 1985. Pseudovobparicine, a new dimeric indole Alkaloid from Tabernaemontaneae divaricate. Planta Medica; 3: 227-9-79.

Marion G, Christiane D, Alexandre D, Lionel D, Roger J, Lucile A, Rasoanaivo P, 2012. Indole alkaloids from Muntafara sessilifolia with antiplasmodial and cytotoxic activities. Phytochemistry; 73: 65 – 73.

Wasana P, Anchalee P, Nipon C, Siriporn C, 2006. Ethnobotany and Ethnopharmacology of Tabernaemontaneae divaricate. Indian J. Med Res; 127: 317 – 335

Taesotikul T, Panthong A, Kajanapothi D, Verpoorte R, Scheffer JJ, 2003. Cardiovascular effects of Tabernaemontaneae pandacaqui. J. Ethnopharmacology; 27: 107-

Ponglux D, Wongseripipatana S, Sudhadhirasakui S, Takayma H, Yokota M, Ogata K, 1988

Studies on the indole alkaloid of gelsemium elegans (Thailand): Structure elucidation and proposal of biogenetic route. Tetrahedron ; 44: 5075-5094.

Marion G, Laval-Jeantet, 2006. Iboga : invisible et guérison, une approche ethno-psychiatrique. Edition CQFD, Paris; 15: 216-219.

Scheffers IJ, 2010. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J. Am. Coll. Cardiol. 56: 1254-1258.

Sarbanes K, Kruse MN, Gazinski A, Kuhn M, 2009. Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1. Endocrinology; 150: 2382 – 2387.

Akizuki O, 2008. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCl-H295R. Eur. J. Pharmacol. 584 : 424 – 434.

Bruneton J, 2002. Pharmacognosie, Phytochimie des plantes médicinales, Edition 3, Lavoisier, Paris ; 242 p.



  • There are currently no refbacks.

Copyright (c) 2023 Audiat Miller Miller

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.